ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

“Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says

September 25, 1998

NCCN Launches Outcomes Improvement Program

August 12, 2011

Program Announcements n Animal Retroviruses, Other Topics, Approved

March 30, 1990

Genetics Flexes Muscle At AACR Annual Meeting, Joint Session With ASCO On Genetic Charges

May 24, 1991

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999